133 related articles for article (PubMed ID: 4210027)
1. [Insulin secretion after administration of sulfonylurea in normal and diabetic subjects].
Okajima J
Nihon Naibunpi Gakkai Zasshi; 1974 Jan; 50(1):19-29. PubMed ID: 4210027
[No Abstract] [Full Text] [Related]
2. Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects.
Haupt E; Köberich W; Beyer J; Schöffling K
Diabetologia; 1971 Dec; 7(6):449-54. PubMed ID: 5004178
[No Abstract] [Full Text] [Related]
3. [Blood sugar, serum insulin, nonesterified fatty acids and somatotropin in daily profile in adult diabetics under monotherapy with various sulfonylureas].
Happ J; Beyer J; Nest E; Fröhlich A; Althoff PH; Schöffling K
Arzneimittelforschung; 1974 Aug; 24(8):1228-34. PubMed ID: 4214173
[No Abstract] [Full Text] [Related]
4. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
Haupt E; Beyer J; Schöffling K
Dtsch Med Wochenschr; 1974 Mar; 99(9):385-8. PubMed ID: 4208186
[No Abstract] [Full Text] [Related]
5. [The response of serum glucose, free fatty acid and immunoreactive insulin to oral glucose and intravenous tolbutamide in normal, potentially diabetic and diabetic subjects].
Bigelow-Sherman JD; Shima K; Borden EK; Foà PP; Penhallegon R
Acta Diabetol Lat; 1970; 7(1):68-92. PubMed ID: 5493440
[No Abstract] [Full Text] [Related]
6. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
Lauvaux JP; Mandart G; Heymans G; Ooms HA
Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
[No Abstract] [Full Text] [Related]
7. Abnormal serum growth hormone responses in genetically potential-diabetic male patients with normal oral glucose tolerance: evidence for an insulin-like action of growth hormone in vivo.
Sönksen PH; Soeldner JS; Gleason RE; Boden G
Diabetologia; 1973 Oct; 9(5):426-37. PubMed ID: 4773203
[No Abstract] [Full Text] [Related]
8. [Comparative use of gliquidone and tolbutamide administered intravenously].
Zilker T; Lüders L; Bottermann P
MMW Munch Med Wochenschr; 1975 Sep; 117(36):1421-2. PubMed ID: 126376
[No Abstract] [Full Text] [Related]
9. An unusual form of diabetes mellitus in ataxia telangiectasia.
Schalch DS; McFarlin DE; Barlow MH
N Engl J Med; 1970 Jun; 282(25):1396-402. PubMed ID: 4192270
[No Abstract] [Full Text] [Related]
10. Plasma insulin response during oral glucose tolerance tests in newborns of normal and gestational diabetic mothers.
Pildes RS; Hart RJ; Warrner R; Cornblath M
Pediatrics; 1969 Jul; 44(1):76-83. PubMed ID: 5795407
[No Abstract] [Full Text] [Related]
11. Dose-response relationships of tolbutamide and glibenclamide in diabetes mellitus.
Heine P; Kewitz H; Schnapperelle U
Eur J Clin Pharmacol; 1974 Aug; 7(5):321-30. PubMed ID: 4213593
[No Abstract] [Full Text] [Related]
12. [Insulin liberation by blood sugar decreasing sulfonamides and by glucose in adult diabetic patients].
Haupt E; Köberich W; Rosak C; Beyer J; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2198. PubMed ID: 4198967
[No Abstract] [Full Text] [Related]
13. Extrainsular mechanisms of glucose disposal in adult-onset diabetes.
Fabrykant M; Gelfand ML; Ortega AA; Buffone ER; Manrique JV
Am J Med Sci; 1971 Apr; 261(4):197-205. PubMed ID: 5578774
[No Abstract] [Full Text] [Related]
14. [Effect of gliquidone and glibenclamide following oral administration].
Ziler T; Waldthaler A; Ermler R; Bottermann P
MMW Munch Med Wochenschr; 1975 Sep; 117(36):1423-4. PubMed ID: 809687
[TBL] [Abstract][Full Text] [Related]
15. [Diminution of delay in insulin secretion in early diabetes mellitus with ongoing tolbutamide treatment].
Nadeau A; Catellier C
Union Med Can; 1974 Mar; 103(3):413-7. PubMed ID: 4820869
[No Abstract] [Full Text] [Related]
16. [Influence of therapy on glucose and lipid metabolism as well as insulin secretion in diabetes mellitus].
Lohmann D; Verlohren HJ; Pohl A; Brückner U
Dtsch Z Verdau Stoffwechselkr; 1976; 36(2):77-84. PubMed ID: 1017406
[No Abstract] [Full Text] [Related]
17. Elevated serum human growth hormone and decreased serum insulin in prediabetic males after intravenous tolbutamide and glucose.
Boden G; Soeldner JS; Gleason RE; Marble A
J Clin Invest; 1968 Apr; 47(4):729-39. PubMed ID: 5641614
[TBL] [Abstract][Full Text] [Related]
18. Investigations on the antilipolytic activity of sulfonylureas in man with indications on limit dosages concerning their insulin-secreting properties.
Rosak C; Haupt E; Beyer J; Schöffling K
Horm Metab Res; 1974 Nov; 6(6):464-70. PubMed ID: 4217757
[No Abstract] [Full Text] [Related]
19. Insulin reserve in patients with chronic pancreatitis.
Joffe BI; Bank S; Jackson WP; Keller P; O'Reilly IG; Vinik AI
Lancet; 1968 Oct; 2(7574):890-2. PubMed ID: 4176149
[No Abstract] [Full Text] [Related]
20. Offspring of two diabetic parents: differential serum insulin responses to intravenous glucose and tolbutamide.
Rojas L; Soeldner JS; Gleason RE; Kahn CB; Marble A
J Clin Endocrinol Metab; 1969 Dec; 29(12):1569-79. PubMed ID: 4899852
[No Abstract] [Full Text] [Related]
[Next] [New Search]
